Institutional investors purchased a net $5.9 million shares of THRX during the quarter ended December 2014. This may signal that the smart money is gaining interest in this company as the 89.99% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
IRIDIAN ASSET MANAGEMENT LLC Bought 3.2 Million shares of Theravance Inc
MANULIFE ASSET MANAGEMENT (US) L... Bought 2.7 Million shares of Theravance Inc
PERRY CORP. (NEW YORK) Bought 2.2 Million shares of Theravance Inc